Wholesale
Therapeutic Areas
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Celecoxib | 200mg | Capsule |
| Ketorolac trometamol | 30mg/mL | Solution for Injection |
| Paracetamol | 500mg | Tablet |
| Paracetamol + Tramadol hydrochloride | 325mg/37.5mg | Tablet |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Salbutamol as sulfate | 100mcg per actuation | Metered Dose Inhaler |
| Salbutamol as sulfate + Ipratropium bromide | 100mcg/20mcg per actuation | Metered Dose Inhaler |
| Salmeterol as xinafoate + Fluticasone propionate | 25mcg/50mcg; 25mcg/125mcg; and 25mcg/250mcg per actuation | Metered Dose Inhaler |
| Salmeterol xinafoate + Fluticasone propionate | 50mcg/100mcg; 50mcg/250mcg; and 50mcg/500mcg | Dry Powder for Inhalation in Capsule |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Amikacin (as sulfate) | 50mg/mL; and 250mg/mL | Solution for Injection |
| Amoxicillin as trihydrate | 125mg; and 250mg | Dispersible Tablet for Oral Suspension |
| Azithromycin as dihydrate | 500mg | Film Coated Tablet |
| Ciprofloxacin as HCI | 2mg/ml | Solution for IV Infusion |
| Clindamycin as HCI | 150mg; and 300mg | Capsule |
| Clindamycin as HCI | 150mg/ml | Solution for Injection |
| Clindamycin as phosphate | 150mg/ml | Solution for Injection |
| Cloxacillin as sodium | 500mg | Capsule |
| Cloxacillin as sodium | 500mg | Powder for Injection |
| Co-Amoxiclav | 228.5mg/5mL | Powder for Oral Suspension |
| Co-Amoxiclav | 228.5mg; and 312.5mg | Dispersible Tablet |
| Co-Amoxiclav | 457mg/5mL | Powder for Oral Suspension |
| Co-Amoxiclav | 625mg; and 1g | Film Coated Tablet |
| Co-Amoxiclav | 1g/200mg | Powder for Solution for Injection |
| Levofloxacin as hemihydrate | 250mg | Tablet |
| Levofloxacin as hemihydrate | 500mg | Film Coated Tablet |
| Levofloxacin as hemihydrate | 500mg/100ml | Solution for IV Infusion |
| Meropenem (as trihydrate) | 500mg; and 1g | Powder for Injection (IV Infusion) |
| Meropenem | 500mg; and 1g | Powder for IV Injection |
| Ofloxacin | 2mg/ml (200mg/100ml) | Solution for Intravenous Infusion |
| Oxacillin as sodium | 500mg; and 1g | Powder for Injection |
| Piperacillin sodium + Tazobactam sodium | 4g/500mg | Powder for Injection |
| Sultamicillin as tosilate dihydrate | 375mg | Film Coated Tablet |
| Cefixime (as hydrochloride) | 100mg | Capsule |
| Cefixime (as hydrochloride) | 400mg | Capsule |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Rosuvastatin as calcium | 10mg; and 20mg | Film Coated Tablet |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Sitagliptin as phosphate monohydrate | 50mg; and 100mg | Film Coated Tablet |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Fluconazole | 2mg/ml ( 200mg/100ml ) | Solution for Intravenous Infusion |
| Nystatin | 100,000IU/ml | Oral Suspension (Drops) |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Diphenhydramine HCI | 50mg/ml | Solution for Injection |
| Hydroxyzine Hydrochloride | 25mg | Tablet |
| Montelukast as sodium + Levocetirizine dihydrochloride | 10mg/5mg | Film Coated Tablet |
| Olopatadine as HCI | 6mg/ml ( 0.6% w/v ) | Solution for Nasal Spray |
| Montelukast (as sodium) | 4mg | Chewable Tablet |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Hydralazine HCI | 20mg/mL | Solution for Injection |
| Ivabradine as HCI | 7.5mg | Film Coated Tablet |
| Nicardipine Hydrochloride | 1mg/mL | Solution for Injection |
| Olmesartan Medoxomil | 10mg; and 20mg | Film Coated Tablet |
| Spironolactone | 25mg | Film Coated Tablet |
| Spironolactone | 50mg | Film Coated Tablet |
| Bisoprolol Fumarate | 2.5mg | Film Coated Tablet |
| Clonidine hydrochloride | 7.5mg | Tablet |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Anastrozole | 1mg | Film Coated Tablet |
| Bortezomib | 3.5mg | Lyophilized Powder for Injection |
| Carboplatin | 10mg/ml | Solution for Injection |
| Cisplatin | 1mg/ml | Solution for Injection |
| Docetaxel (as trihydrate) | 10mg/mL (20mg/2mL); 10mg/mL (80mg/8mL); and 10mg/mL (120mg/12mL) | Solution for Intravenous Infusion |
| Docetaxel (as trihydrate) | 20mg/0.5ml; 20mg/ml; 80mg/4ml; and 120mg/6ml | Conc. Solution for IV Infusion |
| Doxorubicin as HCI | 10mg; and 50mg | Lyophilized Powder for Injection |
| Epirubicin as HCI | 50mg | Lyophilized Powder for Intravenous Injection |
| Gemcitabine | 200mg; and 1g | Lyophilized Powder for Injection |
| Hydroxyurea | 500mg | Capsule |
| Imatinib as mesilate | 100mg; and 400mg | Capsule |
| Irinotecan HCI as trihydrate | 20mg/ml (40mg/2mL and 100mg/5mL) | Conc. for Solution for Infusion |
| Letrozole | 2.5mg | Film Coated Tablet |
| Methotrexate | 2.5mg | Tablet |
| Methotrexate | 25mg/ml (50mg/2ml) | Solution for Injection |
| Oxaliplatin | 2mg/ml (50mg/25ml); and 2mg/ml (100mg/50ml) | Solution for IV Infusion |
| Paclitaxel | 6mg per ml | Solution for Injection |
| Tamoxifen as citrate | 20mg | Tablet |
| Zoledronic Acid as monohydrate | 4mg/vial | Lyophilized Powder for IV Infusion |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Metronidazole | 5mg/ml ( 500mg/100ml ) | Solution for IV Infusion |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Potassium Citrate | 1.080g | Extended Release Tablet |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Ursodeoxycholic Acid | 300mg | Tablet |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Gabapentin | 100mg; 300mg; and 400mg | Capsule |
| Pregabalin | 75mg; and 150mg | Capsule |
| Olanzapine | 5mg; 10mg; 15mg; and 20mg | Orodispersible Tablet |
| Risperidone | 2mg | Orally Disintegrating Tablet |
| Sodium valproate | 200mg/5mL | Oral Solution |
| GENERIC NAME | DOSAGE STRENGTH | DOSAGE FORM |
| Fluticasone Propionate | 500mcg/ml (0.05% w/v ) 50 mcg per actuation | Suspension for Nasal Spray |
| Hydrocortisone | 10mg | Tablet |
| Hydrocortisone as sodium succinate | 100mg; 250mg; and 500mg | Lyophilized Powder for Injection |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Whey Protein Powdered Drink (Vanilla Flavor) (Food for Special Medical Purposes for the Dietary Management of Renal Insufficiency) | na | Powdered Drink |
| Nutritional Drink Powder Orange and Vanilla Flavor (For the Dietary Management of Chronic Renal Disease) | na | Powdered Drink |
| GENERIC NAME | DOSAGE STRENGTH | DOSAGE FORM |
| Mycophenolate mofetil | 250mg | Capsule |
| Mycophenolate mofetil | 500mg | Tablet |
| Fingolimod | 500mcg | Capsule |
| GENERIC NAME | DOSAGE STRENGTH | DOSAGE FORM |
| 0.9% Sodium Chloride | 0.9% | Solution for IV Infusion |
| 5% Dextrose in 0.3% Sodium Chloride | 5g/300mg per 100ml | Solution for IV Infusion |
| 5% Dextrose in 0.9% Sodium Chloride | 5g/900mg per 100ml | Solution for IV Infusion |
| 5% Dextrose | 5% | Solutioin for Infusion |
| 10% Dextrose | 10g/100ml (10% w/v) | Solution for Injection (IV Infusion) |
| Lactated Ringer’s Solution | na | Solution for IV Infusion |
| GENERIC NAME | DOSAGE STRENGTH | DOSAGE FORM |
| Lidocaine as hydrochloride / Epinephrine as bitartrate | 20mg/0.0125mg per ml | Solution for Injection ( Dental Infiltration ) |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Acetylcysteine | 100mg/5ml | Syrup |
| Acetylcysteine | 100mg; and 200mg | Granules for Suspension |
| Acetylcysteine | 100mg/ml | Solution for IV Infusion |
| Acetylcysteine | 100mg/ml | Solution for Inhalation |
| GENERIC NAME | DOSAGE STRENGTH | DOSAGE FORM |
| Esomeprazole as sodium | 20mg | Enteric Coated Tablet |
| Esomeprazole as sodium | 40mg | Delayed Release Tablet |
| Esomeprazole as sodium | 40mg | Lyophilized Powder for IV Injection/Infusion |
| Pantoprazole as sodium sesquihydrate | 40mg | Lyophilized Powder for Injection |
| Pantoprazole as sodium sesquihydrate + Domperidone | 40mg/30mg | Capsule |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Cetrorelix (as acetate) | 250mcg | Lyophilized Powder for Injection |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Atosiban as acetate | 7.5mg/ml ( 6.75mg/0.9ml ); and 7.5mg/ml ( 6.75mg/0.9ml ) | Solution for Injection |
| Isoxsuprine as HCI | 5mg/ml | Solution for Injection |
| Isoxsuprine as HCI | 10mg | Tablet |
| GENERIC NAME | AVAILABLE DOSAGE STRENGTH | DOSAGE FORM |
| Amino Acid | n/a | Solution for Injection |
| 5% Amino Acids + 5% Sorbitol | n/a | Solution for Intravenous Infusion for Injection |
| Amino Acids + Multivitamins | n/a | Caspule |
| Amino Acids + Multivitamins + Minerals | n/a | Capsule |
